Eli Lilly (LLY) Return on Equity [ROE] (2009 - 2026)
Eli Lilly (LLY) reported Return on Equity [ROE] of 74.39% for Q3 2026, down 12.87 percentage points from 87.26% a year earlier and down 7.70 percentage points from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Eli Lilly posted Return on Equity [ROE] of 101.16%, up 16.90 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -44.16 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at 84.26% in FY2024 (+35.83 pp), 48.43% in FY2023 (-14.24 pp), 62.67% in FY2022 (-11.86 pp) and 74.52% in FY2021 (-70.80 pp).
- The Q3 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q1 2025.
- Year over year, Return on Equity [ROE] gained in seven of the last eight quarters, with an average year-over-year change of +13.98 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q3 2025 (a gain of 27.39 percentage points); the low point was Q4 2021 (a drop of 49.22 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 82.09% (Q2 2026), 87.57% (Q1 2026) and 81.93% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 19.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 74.39% |
| Jun 30, 2026 | 82.09% |
| Mar 31, 2026 | 87.57% |
| Dec 31, 2025 | 81.93% |
| Sep 30, 2025 | 87.26% |
| Jun 30, 2025 | 80.71% |
| Mar 31, 2025 | 73.75% |
| Dec 31, 2024 | 74.07% |
| Sep 30, 2024 | 59.88% |
| Jun 30, 2024 | 55.34% |
| Mar 31, 2024 | 51.66% |
| Dec 31, 2023 | 47.27% |
| Sep 30, 2023 | 44.43% |
| Jun 30, 2023 | 57.90% |
| Mar 31, 2023 | 51.53% |
| Dec 31, 2022 | 59.64% |
| Sep 30, 2022 | 64.10% |
| Jun 30, 2022 | 62.82% |
| Mar 31, 2022 | 65.85% |
| Dec 31, 2021 | 65.25% |
API Access
Eli Lilly Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();